Wasatch Advisors LP cut its holdings in Balchem Co. (NASDAQ:BCPC - Free Report) by 11.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,202,354 shares of the basic materials company's stock after selling 152,764 shares during the period. Wasatch Advisors LP owned 3.70% of Balchem worth $195,978,000 as of its most recent SEC filing.
Several other institutional investors have also recently made changes to their positions in BCPC. Covestor Ltd boosted its position in Balchem by 93.8% during the fourth quarter. Covestor Ltd now owns 157 shares of the basic materials company's stock valued at $26,000 after buying an additional 76 shares during the period. Westside Investment Management Inc. purchased a new position in shares of Balchem in the third quarter worth $27,000. R Squared Ltd purchased a new stake in Balchem during the 4th quarter valued at $29,000. Federated Hermes Inc. bought a new stake in Balchem during the fourth quarter valued at about $33,000. Finally, Wilmington Savings Fund Society FSB bought a new position in Balchem in the 3rd quarter worth $35,000. Institutional investors own 87.91% of the company's stock.
Wall Street Analysts Forecast Growth
Several research firms recently weighed in on BCPC. Sidoti upgraded Balchem to a "hold" rating in a report on Tuesday, February 25th. StockNews.com downgraded shares of Balchem from a "buy" rating to a "hold" rating in a report on Tuesday, February 25th. Finally, HC Wainwright reaffirmed a "buy" rating and issued a $190.00 price objective on shares of Balchem in a research report on Monday, February 24th.
View Our Latest Analysis on BCPC
Balchem Stock Down 2.0 %
Shares of NASDAQ:BCPC traded down $3.20 during trading hours on Monday, reaching $158.30. The stock had a trading volume of 35,594 shares, compared to its average volume of 129,283. Balchem Co. has a 1 year low of $137.69 and a 1 year high of $186.03. The stock has a market capitalization of $5.15 billion, a price-to-earnings ratio of 40.28, a P/E/G ratio of 4.41 and a beta of 0.75. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.16 and a current ratio of 1.99. The firm's 50 day moving average is $164.84 and its 200-day moving average is $167.65.
Balchem (NASDAQ:BCPC - Get Free Report) last released its quarterly earnings data on Friday, February 21st. The basic materials company reported $1.03 EPS for the quarter, missing analysts' consensus estimates of $1.11 by ($0.08). The company had revenue of $240.00 million for the quarter, compared to analysts' expectations of $239.96 million. Balchem had a return on equity of 11.37% and a net margin of 13.47%. Research analysts predict that Balchem Co. will post 4.64 earnings per share for the current fiscal year.
About Balchem
(
Free Report)
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.
Featured Stories
Before you consider Balchem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Balchem wasn't on the list.
While Balchem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
